Atea Pharmaceuticals is trading 5.18% down at $4.94 on October 1, 2026; no specific reason for the decline has been confirmed. - No new company announcement or clear company-specific catalyst was identified; the latest release on the investor-relations page is dated September 8. - Rising Treasury yields and macroeconomic uncertainty are broader market factors, but the provided index moves are modest and do not establish that they caused the decline.